Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Cypress, California Clinical Trials

A listing of Cypress, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (921) clinical trials

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Moderate to Severe Crohn's Disease

The purpose of this study is to evaluate the potential effects of an intravenous (IV) induction and subcutaneous (SC) maintenance administration of ustekinumab on the pharmacokinetic (PK) of a cocktail of representative probe substrates of cytochrome P450 (CYP) enzymes (CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2) in participants with moderate to ...

Phase

0.05 miles

Learn More »

PK and PD Profile of Dance 501 in Healthy Non-diabetic Subjects With Mild to Moderate Asthma or COPD

The PK and PD profile of Dance 501 (Human Insulin Inhalation Solution and Inhaler) will be compared to subcutaneous injection of insulin lispro.

Phase

0.05 miles

Learn More »

A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy Adults

The purpose of this study is to assess the pharmacokinetics of single-dose evening administration of JNJ-42847922 in elderly non-Asian adults compared with weight- and gender-matched young healthy non-Asian adults and to assess the pharmacokinetics of single-dose evening administration of JNJ-42847922 in healthy Japanese adults.

Phase

0.1 miles

Learn More »

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD) Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

"This is a single-center, randomized, double-blind, and placebo-controlled trial designed to: demonstrate the degree to which administered andexanet doses can reverse Factor Ten A (FXa)-inhibitor induced anticoagulation; and 2) evaluate the safety and PK/PD of andexanet in healthy Japanese subjects taking direct FXa inhibitors at therapeutic doses."

Phase

0.1 miles

Learn More »

Safety Tolerability Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

The purpose of the present study is to assess the effects of LMB763 with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH

Phase

0.1 miles

Learn More »

A Multiple Dose Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants

The purpose of this study is to assess the safety and tolerability of BMS-986263 in healthy volunteers.

Phase

0.1 miles

Learn More »

Do you have Rheumatoid Arthritis? WCCT Global is seeking volunteers who have been diagnosed with Rheumatoid Arthritis for at least 6 months to participate in a medical research study with an investigational medication. Participants may receive: Up to $2,350 for time and travel Study related care at no cost Investigational ...

Phase

0.1 miles

Learn More »

Are You Healthy? WCCT Global is looking for healthy males and females ages 18 to 49 to participate in a clinical research study with an investigational medication. Qualified participants may receive: Up to $1,200 for time and travel Study related care at no cost An investigational medication To see if ...

Phase

0.1 miles

Learn More »

WCCT Global is seeking males and females ages 20 to 75 years old that are diagnosed with Osteopenia and currently on Glucocorticoids to participate in a clinical research study of an investigational drug. Your participation is necessary for new and innovative treatments for Osteopenia.

Phase

0.1 miles

Learn More »

A Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophic Scar

This single-center, randomized, double-blind, within-subject placebo controlled study is designed to evaluate the safety and efficacy of various doses of STP705 administered as intradermal injection in subjects with linear hypertrophic scar. Twenty four subjects will be divided equally among 3 cohorts (20, 30 and 40 g/cm2/day dose level) of 8 ...

Phase

0.1 miles

Learn More »